Janssen Pharmaceuticals, Inc.

United States of America

 
Total IP 428
Total IP incl. subs 521 (+ 93 for subs)
Total IP Rank # 3,032
IP Activity Score 3.3/5.0    349
IP Activity Rank # 2,050
IP AS incl. subs 3/5.0    353
Parent Entity Johnson & Johnson
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

195 0
78 0
154 0
1
 
Last Patent 2025 - Compositions and methods for the...
First Patent 1981 - Pre-filled syringe for abusable ...
Last Trademark 2019 - SUVRILO
First Trademark 2019 - SUVRILO

Subsidiaries

3 subsidiaries with IP (93 patents, 0 trademarks)

1 subsidiaries without IP

 Register for free to unlock the subsidiary list

Industry (Nice Classification)

Latest Inventions, Goods, Services

2025 Invention Mdr e. coli immunogen. The subject relates to an isolated antibody that specifically binds to O2...
Invention Liposomes containing phosphorylated tau peptides for inducing sustained immune responses. Method...
2024 Invention Anti-respiratory syncytial virus antibodies and uses thereof. Provided herein are antibodies and ...
Invention Systems and methods for sterilizing mass flow meters and their use for precise pharmaceutical con...
Invention Compositions and methods for the treatment of depression. The disclosure provides methods for tr...
Invention Tau active functional assays. The application describes methods for evaluating the capacity of an...
Invention Method of treating preclinicial alzheimer's disease. The application describes a phosphorylated t...
Invention Method of treating preclinicial alzheimer's disease. The application describes a phosphorylated ...
Invention Compositions comprising aticaprant for use in treating major depressive disorder. The present dis...
Invention Method for quantifying bound acetate in glycoconjugates. The present invention relates to a metho...
Invention Intranasal administration of esketamine. The present invention is directed to pharmaceutical pro...
Invention Forms of aticaprant. The disclosure provides crystalline and amorphous forms of aticaprant. Also ...
Invention Fimh mutant, compositions therewith and use thereof. Polypeptides comprising a FimH lectin domai...
Invention Compositions comprising aticaprant. The present disclosure relates to compositions, including ora...
Invention Compositions and methods for the treatment of depression. The disclosure provides methods for tre...
Invention Bioconjugates of e. coli o-antigen polysaccharides, methods of production thereof, and methods of...
2023 Invention Bioconjugate compositions and process for bioconjugate production. The present invention relates ...
Invention Multivalent vaccine compositions and uses thereof. Compositions and methods are described for ind...
Invention Expec glycoconjugate vaccine formulations. Compositions and methods for inducing an immune respo...
Invention Compositions and methods for enhancing gene expression. The present disclosure generally relates...
Invention Induce and enhance immune responses using recombinant replicon systems. The present disclosure g...
Invention Mono- or di-substituted indole derivatives as dengue viral replication inhibitors. The present in...
Invention Esketamine for the treatment of depression. The present invention provides methods of maintainin...
Invention Fimh mutants, compositions therewith and use thereof. Polypeptides comprising a FimH lectin domai...
Invention Method of safe administration of phosphorylated tau peptide vaccine. Methods for inducing anti-ph...
Invention Mrna compositions for inducing latent hiv-1 reversal. The present disclosure includes mRNA compos...
Invention Treatment or prevention of dengue viral infection. The present invention relates to a compound of...
Invention Treatment or prevention of dengue viral infection. 1233132331233313231332313233132333.
Invention Vial holder. Various exemplary methods, systems, and devices for vial holders are provided. The v...
Invention Pure forms of crystalline aticaprant. The disclosure provides compositions containing pure atica...
2022 Invention Anti-human vista antibodies and use thereof. The invention provides antagonistic and agonistic a...
Invention Method of safe administration of tau phosphopeptide conjugate. Methods for inducing anti-phospho...
Invention Processes for the preparation of (s)-2-(4-chloro-2-methoxyphenyl)-2-((3 -methoxy-5-(m ethylsulfon...
Invention Single vial holder
Invention Dual vial holder
Invention Process for bioconjugate production. The present invention relates to a process for the producti...
2021 Invention Analytical method for glycogonjugates using a capillary-based immunoassay system. The invention ...
Invention Solid formulation. The invention relates to pharmaceutical formulations comprising an active pha...
Invention Variant staphylococcus aureus luka and lukb polypeptides and vaccine compositions. The present d...
Invention Stabilized coronavirus spike protein fusion proteins. The present invention provides stabilized ...
2020 Invention Drug delivery adjustment. Provided herein are drug administration devices, methods, and systems ...
Invention Drug administration device and system for establishing a dosage regimen and compatibility of comp...
2019 G/S Pharmaceutical preparations, in particular for the treatment of multiple sclerosis.